0.55
+0.0105(+1.94%)
Currency In USD
| Previous Close | 0.54 |
| Open | 0.55 |
| Day High | 0.57 |
| Day Low | 0.53 |
| 52-Week High | 4.8 |
| 52-Week Low | 0.47 |
| Volume | 177,106 |
| Average Volume | 829,393 |
| Market Cap | 18.99M |
| PE | -0.26 |
| EPS | -2.11 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 1.59 |
| Change | 0.01 |
If you invested $1000 in Inotiv, Inc. (NOTV) 10 years ago, it would be worth $391.99 as of January 22, 2026 at a share price of $0.553. Whereas If you bought $1000 worth of Inotiv, Inc. (NOTV) shares 5 years ago, it would be worth $37.7 as of January 22, 2026 at a share price of $0.553.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
GlobeNewswire Inc.
Jan 13, 2026 2:15 PM GMT
WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and resear
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
GlobeNewswire Inc.
Dec 11, 2025 2:00 PM GMT
WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery and development services and
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
GlobeNewswire Inc.
Nov 25, 2025 12:00 PM GMT
Building a Unified, Client-Focused, Early Stage CRO Through Strategic Expansion and Service Development Powers 448% Revenue Growth from Fiscal Year 2021 to Fiscal Year 2024WEST LAFAYETTE, Ind., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Inotiv today announc